secwatch / observer

Earnings Releases

Quarterly and annual results disclosed under 8-K Item 2.02.

8-K items 2.02 JSON
SPNT SiriusPoint Ltd

SiriusPoint Ltd reported first quarter ended March 31, 2026 results: net income $100 million, EPS $0.82 per diluted common share.

“Net income available to SiriusPoint common shareholders of $100 million, or $0.82 per diluted common share”
GH Guardant Health, Inc.

Guardant Health, Inc. reported the quarter ended March 31, 2026 results: revenue $301.7 million. Guidance raised.

“March 31, 2026. First Quarter 2026 Financial Highlights For the three-month period ended March 31, 2026, as compared to the same period of 2025: • Reported total revenue of $301.7 million, an increase of 48%, driven by: ◦ Oncology revenue of $205.0 million, an increase of 36%, and approximately 86,000 oncology tests, an increase of 47% ◦ Biopharma & Data revenue”
MMI Marcus & Millichap, Inc.

Marcus & Millichap, Inc. reported first quarter ended March 31, 2026 results: revenue $171.5 million, net income Net loss of $3.1 million, EPS $0.08 per common share, diluted.

“First Quarter 2026 Highlights Compared to First Quarter 2025 • Total revenue of $171.5 million, an increase of 18.2% compared to $145.0 million • Brokerage commissions of $138.1 million, an increase of 11.7% compared to $123.6 million • Private Client Market brokerage revenue of $88.1 million, an increase of 13.4% compared to $77.7 million • Middle Market and Larger Transaction Market brokerage revenue of $44.6 million, an increase of 9.2% compared to $40.9 million • Financing fees of $26.8 million, an increase of 48.1% compared to $18.1 million • Pre-tax loss of $2.2 million compared to $13.9 million, an improvement of 84.4% • Net loss of $3.1 million, or $0.08 per common share, diluted, compared to a net loss of $4.4 million, or $0.11 per common share, diluted • Adjusted EBITDA 1 of $2.9 million compared to $(8.7) million, an improvement of 133.7%.”
VITL Vital Farms, Inc.

Vital Farms, Inc. reported the first quarter ended March 29, 2026 results: revenue $187.2 million, net income Net Loss of $1.5 million, EPS Net Loss per Diluted Share of $0.03. Guidance lowered.

“Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its first quarter ended March 29, 2026. Financial highlights for the first quarter ended March 29, 2026, compared to the first quarter ended March 30, 2025, include: • Net Revenue increased 15.4% to $187.2 million, compared to $162.2 million • Gross Margin of 28.3%, compared to 38.5% • Net Loss of $1.5 million, compared to Net Income of $16.9 million • Net Loss per Diluted Share of $0.03, compared to Net Income per Diluted Share of $0.37 • Adjusted EBITDA of $5.0 million, compared to $27.5 million”
OUT OUTFRONT Media Inc.

OUTFRONT Media Inc. reported first quarter ended March 31, 2026 results: revenue $429.6 million, net income $19.1 million, EPS $0.11.

“OUTFRONT Media Reports First Quarter 2026 Results Revenues of $429.6 million Operating income of $55.9 million Net income attributable to OUTFRONT Media Inc. of $19.1 million Adjusted OIBDA of $100.4 million AFFO attributable to OUTFRONT Media Inc. of $61.0 million Quarterly dividend of $0.30 per share, payable June 30, 2026 NEW YORK, May 7, 2026 – OUTFRONT Media Inc. (NYSE: OUT) today reported results for the quarter ended March 31, 2026.”
IBP Installed Building Products, Inc.

Installed Building Products, Inc. reported the first quarter ended March 31, 2026 results: revenue $660.5 million, net income $34.8 million, EPS $1.29.

“today announced results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights (Comparisons are to Prior Year Period) • Net revenue decreased 3.5% to $660.5 million ◦ Installation revenue decreased 5.8% to $609.8 million, including sales from IBP's recent acquisitions ◦ Other revenue, net of eliminations, which includes IBP’s manufacturing”
XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc. reported financial results for the three months ended March 31, 2026.

“On May 7, 2026, Xenon Pharmaceuticals Inc. (the “Company”) announced via press release the Company’s financial results for the three months ended March 31, 2026.”
CCLD CareCloud, Inc.

CareCloud, Inc. reported the quarter ended March 31, 2026 results: revenue $31.3 million, net income $922,000, EPS ($0.01). Guidance reaffirmed.

“CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026. The Company reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility, the announced redemption of 100% of its Series B Preferred Stock, and AI product launches. Together, these milestones mark a pivotal step in CareCloud’s ongoing growth trajectory—positioning the Company to scale its AI-driven revenue and expand margins, reporting its eighth consecutive quarter of positive GAAP net income with a meaningfully simpler capital structure for the future. First Quarter 2026 Financial Highlights: ● Revenue of $31.3 million, compared to $27.6 million in Q1 2025 ● GAAP net income of $922,000, compared to a net income of $1.9 million in Q1 2025 ● Adjusted EBITD”
TBPH Theravance Biopharma, Inc.

Theravance Biopharma, Inc. reported first quarter of 2026 results: revenue $17.7 million.

“Total revenue for the first quarter of 2026 was $17.7 million, consisting entirely of Viatris collaboration revenue.”
PVLA PALVELLA THERAPEUTICS, INC.

PALVELLA THERAPEUTICS, INC. reported financial results for the first quarter ending March 31, 2026.

“announced its financial results for the quarter ended March 31, 2026”
CTRE CareTrust REIT, Inc.

CareTrust REIT, Inc. reported first quarter ended March 31, 2026 results: net income Net income of $80.2 million, EPS net income per diluted weighted average share of $0.36. Guidance raised.

“Inc. (NYSE:CTRE) today reported operating results for the quarter ended March 31, 2026, as well as other recent events. For the quarter, CareTrust reported: • Net income of $80.2 million and net income per diluted weighted average share of $0.36, an increase of $0.01, or 3%, over the prior year quarter; • Normalized FFO of $107.4 million and Normalized FFO per”
MBUU MALIBU BOATS, INC.

MALIBU BOATS, INC. reported third quarter ended March 31, 2026 results: revenue $235.7 million, net income (net loss of $2.4 million), EPS net loss of $0.13 per share.

“its financial results for the third quarter ended March 31, 2026 . Third Quarter Fiscal 2026 Highlights Compared to Third Quarter Fiscal 2025: • Net sales increased 3.1% to $235.7 million • Unit volume decreased 12.4% to 1,253 units • Gross profit decreased 9.7% to $41.3 million • GAAP net (loss) income decreased from net income of $13.2 million to a net loss of”
GOLD Gold.com, Inc.

Gold.com, Inc. reported financial results for fiscal third quarter ended March 31, 2026.

“On May 6, 2026, Gold.com, Inc. (the “Company”) issued a press release regarding the Company’s financial results for its fiscal third quarter ended March 31, 2026.”
PCTY Paylocity Holding Corp

Paylocity Holding Corp reported three months ended March 31, 2026 results: revenue Total revenue was $502.3 million, net income GAAP net income was $111.3 million, EPS $2.05 per share. Guidance raised.

“Paylocity Announces Third Quarter Fiscal Year 2026 Financial Results • Q3 2026 Recurring & Other Revenue of $469.9 million, up 11.6% year-over-year • Q3 2026 Total Revenue of $502.3 million, up 10.5% year-over-year • Continued growth in cash flows - trailing twelve months net cash provided by operating activities margin of 29.4% and free cash flow margin of 24.4% • Completed acquisition of Grayscale Labs, Inc. in April 2026 to expand AI-powered recruiting capabilities • Repurchased $50 million or 440,000 shares in Q3 2026 and $350 million or 2.3 million shares in the first nine months of fiscal year 2026 • Board of Directors approved a $1.0 billion increase to our share repurchase authorization in April 2026; $1.35 billion authorization available as of May 7, 2026 SCHAUMBURG, IL. – May 7, 2026 – Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, Finance, and IT solutions, today announced financial results for the third quarter of fiscal year 2026, which”
SABR Sabre Corp

Sabre Corp reported the quarter ended March 31, 2026 results: revenue $760 million, net income $8 million. Guidance reaffirmed.

“15% • Sabre's AI platform successfully launched first agentic AI experience for travel with MindTrip and PayPal First Quarter 2026 Financial Results: • First quarter revenue of $760 million, up 8% from Q1'25 • Operating income of $116 million, up 27% from Q1'25 • Net income attributable to common stockholders of $8 million • Adjusted EBITDA (1) of $159 million, up”
HRTG Heritage Insurance Holdings, Inc.

Heritage Insurance Holdings, Inc. reported first quarter of 2026 results: net income net income of $36.5 million, EPS $1.19 per diluted share.

“Heritage reported record first quarter net income of $36.5 million”
DNOW DNOW Inc.

DNOW Inc. reported the quarter ended March 31, 2026 results: revenue $1,183 million, net income $44 million, or ($0.24) per diluted share, EPS ($0.24) per diluted share.

“Controls for $46 million in February, expanding our differentiated automation and controls capabilities within U.S. Process Solutions First Quarter 2026 Highlights • Revenue was $1,183 million • Gross profit was $193 million, or 16.3% of revenue, and adjusted gross profit was $256 million, or 21.6% of revenue • Net loss attributable to DNOW Inc. was $44 million, or”
AUPH Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. updated its the three months ended March 31, 2026 guidance (reaffirmed).

“Aurinia Pharmaceuticals Inc. (Aurinia or the Company) issued a press release announcing its financial results for the quarter ended March 31, 2026.”
XIFR XPLR Infrastructure, LP

XPLR Infrastructure, LP reported first-quarter 2026 results: net income $33 million. Guidance reaffirmed.

“XPLR Infrastructure, LP (NYSE: XIFR) today reported first-quarter 2026 net income attributable to XPLR Infrastructure of $33 million.”
NTRA Natera, Inc.

Natera, Inc. reported first quarter ended March 31, 2026 results: revenue $696.6 million, net income $85.1 million, EPS ($0.60) per diluted share. Guidance raised.

“in cell-free DNA and genetic testing, today reported its financial results for the first quarter ended March 31, 2026. Recent Financial Highlights • Generated total revenues of $696.6 million in the first quarter of 2026, compared to $501.8 million in the first quarter of 2025, an increase of 38.8%. • Generated a gross margin 1 of 64.7% in the first quarter of 2026,”
LOCO El Pollo Loco Holdings, Inc.

El Pollo Loco Holdings, Inc. reported first quarter ended April 1, 2026 results: revenue $126.2 million, net income $8.2 million, EPS $0.27 per diluted share. Guidance raised.

“13-week period ended April 1, 2026. Highlights for the first quarter ended April 1, 2026 compared to the first quarter ended March 26, 2025 were as follows: ● Total revenue was $126.2 million compared to $119.2 million. ● System-wide comparable restaurant sales (1) increased by 5.8%. ● Income from operations was $12.2 million compared to $9.0 million. ● Restaurant”
OMDA Omada Health, Inc.

Omada Health, Inc. reported first quarter ended March 31, 2026 results: revenue $78 million in the first quarter, net income Net loss of $3 million in the first quarter.

“million Total Members at the end of Q1, up 51% year over year, reinforcing Omada’s role as an integrated, multi-condition cardiometabolic platform operating at scale. • Revenue: $78 million in the first quarter, up 42% year over year. • Omada joined Optum Rx’s Weight Engage portfolio to help employers expand responsible, clinically supported access to GLP‐1 and”
JYNT JOINT Corp

JOINT Corp reported the first quarter ended March 31, 2026 results: revenue $14.8 million, net income $1.3 million, EPS $0.09 per diluted share.

“first quarter ended March 31, 2026. The following figures represent continuing operations unless otherwise stated . First Quarter 2026 Financial Highlights • Grew revenues to $14.8 million, a 13% increase compared to the first quarter of 2025. • Reported system-wide sales 1 of $126.1 million, a decline of 4.9%. • Reported comp sales 2 of (4.2)%. • Net income from”
INSE Inspired Entertainment, Inc.

Inspired Entertainment, Inc. reported the first quarter ended March 31, 2026 results: revenue $57.2 million, net income Net Loss of $0.5 million. Guidance reaffirmed.

“INSPIRED REPORTS FIRST QUARTER 2026 RESULTS ● First Quarter Revenue of $57.2 million; Revenue excluding the former UK holiday parks business and restructured pubs business up 15% year-over-year 1 ● First Quarter Net Operating Income of $9.2 million, Net Loss of $0.5 million and Adjusted Net Loss of $0.7 million ● Adjusted EBITDA of $23.7 million, up 29% from prior year, generating a 41% Adjusted EBITDA Margin, driven by portfolio optimization and growth in higher-margin Interactive segment ● Interactive Revenue and Adjusted EBITDA up 38% and 53% year-over-year, respectively ● First quarter Free Cash Flow of $15.8 million 2 ● Repaid $13.3 million of principal of senior secured notes and repurchased 387,230 shares of common stock for $2.6 million ● Reiterating full year 2026 Adjusted EBITDA target range of $112 million to $118 million 3 New York, New York, May 7, 2026 - Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B provider of gaming content, te”
ZIP ZIPRECRUITER, INC.

ZIPRECRUITER, INC. reported the quarter ended March 31, 2026 results: revenue $107.5 million, net income $(4.7) million.

“ZipRecruiter Announces First Quarter 2026 Results Quarterly revenue of $107.5 million Quarterly net loss of $(4.7) million, or net loss margin of (4)% Quarterly Adjusted EBITDA of $9.7 million, or Adjusted EBITDA margin of 9%”
CRBU Caribou Biosciences, Inc.

Caribou Biosciences, Inc. reported financial results for the first quarter of 2026.

“reported financial results for the first quarter of 2026 and provided a business update.”
LONA LeonaBio, Inc.

LeonaBio, Inc. reported financial results for the quarter ended March 31, 2026.

“On May 7, 2026, LeonaBio, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2026.”
SHAK Shake Shack Inc.

Shake Shack Inc. reported the fiscal first quarter ended April 1, 2026 results: revenue $366.7 million, net income Net loss of $0.3 million, EPS loss of $0.01 per diluted share. Guidance raised.

“shall be expressly set forth by specific reference in such a filing. --- EX-99.1 (EX-99.1) --- Shake Shack Announces First Quarter 2026 Financial Results ▪ Total revenue of $366.7 million, up 14.3% versus 2025, including $354.0 million of Shack sales and $12.7 million of Licensing revenue. ▪ System-wide sales of $558.3 million, up 14.1% versus 2025. ▪ Same-Shack”
STOK Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. reported financial results for the first quarter ended March 31, 2026.

“the Company today reported financial results for the first quarter ended March 31, 2026”
CMRC Commerce.com, Inc.

Commerce.com, Inc. reported for its first quarter ended March 31, 2026 results: revenue $86.8 million, net income $3.7 million, EPS $0.05.

“as otherwise stated in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Commerce Announces First Quarter 2026 Financial Results First Quarter Total Revenue of $86.8 Million, an Increase of 5% Versus Prior Year. Total ARR of $359.8 Million, an Increase of 3% Versus Prior Year. GAAP Net Income of $3.7 Million Versus Net Loss in Prior Year Period.”
CRVS Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals, Inc. reported first quarter ended March 31, 2026 results: net income Net loss for the three months ended March 31, 2026 was $13.7 million.

“Net loss for the three months ended March 31, 2026 was $13.7 million”
UPWK UPWORK, INC

UPWORK, INC reported the first quarter of 2026 results: revenue $195.5 million, net income $31.5 million, EPS $0.24. Guidance raised.

“currently impacting the business.” First Quarter 2026 Financial Highlights • GSV (1) was $987.1 million, approximately flat year-over-year • Revenue grew 1% year-over-year to $195.5 million • Active clients (1) of 784,000 • GSV per active client (1) of $5,138 increased 5% year-over-year • GAAP Net income was $31.5 million, a decrease of 17% year-over-year • GAAP”
CWK Cushman & Wakefield Ltd.

Cushman & Wakefield Ltd. reported the first quarter of 2026 results: revenue $2.5 billion, net income Net loss was $12.6 million, EPS Diluted loss per share was $0.05.

“NEW YORK (BUSINESS WIRE), May 7, 2026 — Cushman & Wakefield Ltd. (NYSE: CWK) today reported financial results for the first quarter of 2026. First Quarter Results: • Revenue of $2.5 billion for the first quarter of 2026 increased 11% (9% in local currency) from the first quarter of 2025. ◦ Services revenue increased 9% (7% in local currency), reflecting sustained”
PROF Profound Medical Corp.

Profound Medical Corp. reported the first quarter ended March 31, 2026 results: revenue $5.3 million, net income $7.0 million, EPS $0.19 per common share. Guidance initiated.

“For the quarter ended March 31, 2026, Profound recorded revenue of approximately $5.3 million”
EVH Evolent Health, Inc.

Evolent Health, Inc. reported quarter ended March 31, 2026 results: revenue $496,246, net income $(26,632).

“March 31, 2026 include (dollars in thousands, except for average PMPM fees and revenue per case): For the Three Months Ended March 31, 2026 2025 Financial Results: Revenue $ 496,246 $ 483,649 Net loss attributable to common shareholders of Evolent Health, Inc. $ (26,632) $ (72,250) Net loss margin (5.4) % (14.9) % Adjusted EBITDA $ 22,067 $ 36,860 Adjusted”
AHR American Healthcare REIT, Inc.

American Healthcare REIT, Inc. reported first quarter 2026 results: net income $23.7 million, or $0.13 per diluted share, EPS $0.13 per diluted share. Guidance raised.

“Reported GAAP net income attributable to controlling interest of $23.7 million, or $0.13 per diluted share, for the three months ended March 31, 2026.”
PLNT Planet Fitness, Inc.

Planet Fitness, Inc. reported the quarter ended March 31, 2026 results: revenue $337.2 million, net income $51.6 million, or $0.65 per diluted share.

“reported financial results for its first quarter ended March 31, 2026. First Quarter Fiscal 2026 Highlights • Total revenue increased from the prior year period by 21.9% to $337.2 million. • System-wide same club sales increased 3.5%. • System-wide sales increased $88.0 million to $1.4 billion, from $1.3 billion in the prior year period. • Net income attributable”
MCFT MasterCraft Boat Holdings, Inc.

MasterCraft Boat Holdings, Inc. reported fiscal 2026 third quarter ended March 29, 2026 results: revenue $78.2 million, net income ($0.7) million, EPS ($0.04) per diluted share. Guidance reaffirmed.

“Net sales for the third quarter were $78.2 million, up $2.2 million, or 3.0%, from the comparable prior-year period”
PTON PELOTON INTERACTIVE, INC.

PELOTON INTERACTIVE, INC. reported the quarter ended March 31, 2026 results: revenue $631 million, net income $26 million. Guidance raised.

“NEW YORK, NY – May 7, 2026 – Peloton Interactive, Inc. today reported financial results for the quarter ended March 31, 2026. Q3 FY2026 Financial Highlights • Total Revenue was $631 million, an increase of $7 million or 1% year-over-year and $6 million above our guidance range, primarily driven by outperformance in Connected Fitness equipment sales across both”
VYGR Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. reported first quarter 2026 results: revenue $2.6 million, net income $27.9 million.

“Collaboration revenue was $2.6 million for the three months ended March 31, 2026, compared to $6.5 million for the first quarter of 2025.”
NNDM Nano Dimension Ltd.

Nano Dimension Ltd. reported first quarter ended March 31, 2026 results: revenue $29.7 million, net income Net Loss: $69.7 million.

“the “Company”), a leader in digital manufacturing solutions, today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results: • Revenue: $29.7 million, a 106% increase from $14.4 million year-over-year • Gross Margin (“GM”): 40.8%, up from 40.6% year-over-year • Adjusted Gross Margin (“Adjusted GM”): 45.9%, up from 43.3%”
WSC WillScot Holdings Corp

WillScot Holdings Corp reported first quarter ended March 31, 2026 results: revenue $548,628, net income $28,123, EPS $0.15. Guidance raised.

“leasing revenue inflection now implied in our current outlook." First Quarter 2026 Results 1 Three Months Ended March 31, (in thousands, except share data) 2026 2025 Revenue $ 548,628 $ 559,551 Net income $ 28,123 $ 43,055 Adjusted Net Income $ 38,847 $ 48,658 Adjusted EBITDA $ 211,014 $ 228,785 Gross profit margin 52.1 % 53.7 % Adjusted EBITDA Margin (%) 38.5”
TOST Toast, Inc.

Toast, Inc. reported first quarter ended March 31, 2026 results: net income $126 million, EPS $0.20.

“Financial Results Annualized recurring run-rate (ARR) grew 26% to $2.2 billion as of March 31, 2026 Added approximately 7,000 net new Locations in first quarter Net income was $126 million and Adjusted EBITDA was $179 million in first quarter Repurchased 14 million shares for $378 million year-to-date through May 6, 2026 BOSTON, MA – May 7, 2026 – Toast (NYSE:”
FDMT 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. reported the three months ended March 31, 2026 results: revenue $3.0 million, net income Net loss was $68.8 million.

“fund our operating expenses and capital expenditure requirements at least into the second half of 2028. Collaboration and License Revenue : Collaboration and license revenue was $3.0 million for the first quarter of 2026, as compared to an insignificant amount for the first quarter of 2025. The increase in revenue was primarily due to the clinical trial cost sharing”
ALEC Alector, Inc.

Alector, Inc. reported the quarter ended March 31, 2026 results: revenue $1.0 million, net income $22.9 million, EPS $0.21 per share.

“Revenue. Collaboration revenue for the quarter ended March 31, 2026, was $1.0 million, compared to $3.7 million for the same period in 2025.”
RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp. reported quarter ended March 31, 2026 results: revenue $29.5 million, net income $10.6 million, EPS $0.29 per share.

“Runway Growth Finance Corp. Reports First Quarter 2026 Financial Results Delivered Total and Net Investment Income of $29.5 million and $10.6 million, Respectively Investment Portfolio of $886.3 million”
XMTR Xometry, Inc.

Xometry, Inc. reported the first quarter ended March 31, 2026 results: revenue $205 million, net income $5.3 million, EPS $(0.10).

“stated in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 Xometry Reports Record First Quarter 2026 Results • Q1 revenue increased 36% year-over-year to a record $205 million, driven by robust marketplace growth. • Q1 marketplace revenue growth accelerated to 40% year-over-year, driven by expanding networks of buyers and suppliers and increasing”
KRP Kimbell Royalty Partners, LP

Kimbell Royalty Partners, LP reported financial results for the quarter ended March 31, 2026.

“On May 7, 2026, Kimbell Royalty Partners, LP (the "Partnership") issued a news release announcing its first quarter 2026 financial and operating results.”
HTZ HERTZ GLOBAL HOLDINGS, INC

HERTZ GLOBAL HOLDINGS, INC reported first quarter 2026 results: revenue $2.0 billion, net income $333 million, EPS $(1.06).

“Revenue totaled $2.0 billion in the first quarter, up 11% year over year, Hertz's strongest year-over-year revenue growth in three years, driven by continued progress in its commercial strategies.”
CRNX Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc. reported the first quarter ended March 31, 2026 results: revenue $10.7 million. Guidance reaffirmed.

“ACTH antagonist, atumelnant, in a broad population including patients with both Cushing’s disease and ectopic ACTH syndrome. First Quarter 2026 Financial Results: • Revenue was $10.7 million for the quarter ended March 31, 2026, compared to $0.4 million for the same period in 2025. Revenue for the quarter ended March 31, 2026 includes $10.3 million in net product”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.